TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT05868408: Effect of Partially Hydrolyzed, Whey-based Infant Formulas on Growth and Tolerability in Healthy Term Infants: a Double-blind, Randomized, Controlled, Multi-arm Trial

Sponsor: Société des Produits Nestlé (SPN) · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 234 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$10,624,000

Rescue Site Savings

+$7,005,200

Unlock Full NCT05868408 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT05868408 Rescue Dossier →